EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The long term result of grafted saphenous veins in children with kawasaki disease


, : The long term result of grafted saphenous veins in children with kawasaki disease. Journal of the Japanese Association for Thoracic Surgery 35(1): 54-60

Aortocoronary bypass surgery was performed on eleven children with Kawasaki disease, ranging 5 to 13 years old. Nine cases were bypassed using autologous saphenous vein and left internal mammary artery was utilized in recent two cases. Operative result was gratifying with no death and graft patency one month after surgery was 88% (n = 11). Seven cases with saphenous vein grafts have been followed more than five years and graft patency in those cases at one month, 2-3 years and 5-9 years was 91%, 55% and 55% respectively. Extensive intimal proliferation was considered to be one of the major causes in early graft attrition (graft patency: 91% at one month .fwdarw. 55% at 2-3 years). But those grafts which didn't result early graft failure seemed to have high chance of long term graft patency (55% at 2-3 years .fwdarw. 55% at 5-9 years). And despite of considerable patients growth, there are several grafts which adjusted their lumen and length in this interval. More technical improvement in saphenous vein bypass grafting combined with usage of internal mammary artery will result higher long term graft patency in aortocoronary bypass surgery in the children with Kawasaki disease.


Accession: 006712031

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Takeuchi, Y.; Suma, K.; Inoue, K.; Shiroma, K.; Koyama, Y.; Narumi, J.; Nishiyama, S.; Kaneko, H.; Kohri, Y.; Terada, Y., 1987: The long-term result of grafted saphenous vein in the children with Kawasaki disease. Nihon Kyobu Geka Gakkai 35(1): 54-60

Wakisaka, Y.; Tsuda, E.; Yamada, O.; Yagihara, T.; Kitamura, S., 2008: Long-term results of saphenous vein graft for coronary stenosis caused by Kawasaki disease. Although saphenous vein grafts (SVG) have been used from 1975 to treat coronary stenosis caused by Kawasaki disease, long-term results after more than 20 years remain unknown. From 1981 to 1997, 13 patients underwent coronary artery bypass graftin...

Hammarsten, J.; Pedersen, P.; Cederlund, C.G.; Campanello, M., 1990: Long saphenous vein saving surgery for varicose veins. A long-term follow-up. The autologous saphenous vein is widely recognised as the graft material of choice in infra-inguinal arterial reconstructions. This study was undertaken to evaluate the long-term results of long saphenous vein saving surgery compared with standard...

Anonymous, 1994: Guidelines for long-term management of patients with Kawasaki disease. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Heart Disease and Stroke 3(3): 169-170

Dajani, A.S.; Taubert, K.A.; Takahashi, M.; Bierman, F.Z.; Freed, M.D.; Ferrieri, P.; Gerber, M.; Shulman, S.T.; Karchmer, A.W.; Wilson, W., 1994: Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Long-term management of patients with Kawasaki disease should be tailored to the degree of coronary arterial involvement. This committee has made recommendations for each risk level about antiplatelet and anticoagulant therapy, physical activity,...

Newburger, J.W.; Takahashi, M.; Gerber, M.A.; Gewitz, M.H.; Tani, L.Y.; Burns, J.C.; Shulman, S.T.; Bolger, A.F.; Ferrieri, P.; Baltimore, R.S.; Wilson, W.R.; Baddour, L.M.; Levison, M.E.; Pallasch, T.J.; Falace, D.A.; Taubert, K.A., 2004: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Background-Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopath...

Newburger, J.W.; Takahashi, M.; Gerber, M.A.; Gewitz, M.H.; Tani, L.Y.; Burns, J.C.; Shulman, S.T.; Bolger, A.F.; Ferrieri, P.; Baltimore, R.S.; Wilson, W.R.; Baddour, L.M.; Levison, M.E.; Pallasch, T.J.; Falace, D.A.; Taubert, K.A., 2004: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary...

Louagie, Y.A.; Legrand-Monsieur, A.; Lavenne-Pardonge, E.; Remacle, C.; Delvaux, P.; Maldague, P.; Buche, M.; Ponlot, R.; Schoevaerdts, J.C., 1990: Viability of long-term cryopreserved human saphenous veins. The feasibility of maintaining long-term viability of human venous allografts by cryopreservation has been investigated. Segments of vein were obtained from 85 patients undergoing a stripping operation for varicose veins. The venous segments were...

Schadeck, M.; Allaert, F.A., 1997: Long-term results of sclerotherapy of the great saphenous veins. This work sets a time limit on the prospective study of sclerotherapy of the great saphenous veins which began in 1985. The protocol dictated a single sclerosing injection per session, of an increasing dose comprising 3% 1.5 cc. Trombovar up to 12...

Newburger; Et-Al, 2005: Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (vol 114, pg 1708, 2004). Pediatrics 115(4): 1118